欧洲疾控中心：2025年碳青霉烯类耐药肠杆菌科细菌调查分析计划（CRE25调查）报告（英文版）

For the CRE25 survey main collection, the participating countries are invited to submit Klebsiella pneumoniae species complex (SC) and Escherichia coli isolates that are in the categories ‘resistant’ (R) or ‘susceptible increased exposure’ (I) for any carbapenem in accordance with the European Committee for Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoints. Countries are also invited to voluntarily submit carbapenemase-suspected K. pneumoniae SC and E. coli isolates based on